Daniela Niemeyer
Overview
Explore the profile of Daniela Niemeyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
7311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al.
Nature
. 2025 Feb;
638(8052):E46.
PMID: 39905258
No abstract available.
2.
Ma-Lauer Y, Li P, Niemeyer D, Richter A, Pusl K, von Brunn B, et al.
Front Cell Infect Microbiol
. 2024 Aug;
14:1383917.
PMID: 39119292
Introduction: Oxysterol-binding protein (OSBP) is known for its crucial role in lipid transport, facilitating cholesterol exchange between the Golgi apparatus and endoplasmic reticulum membranes. Despite its established function in cellular...
3.
Muhlemann B, Trimpert J, Walper F, Schmidt M, Jansen J, Schroeder S, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(32):e2310917121.
PMID: 39078681
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has developed substantial antigenic variability. As the majority of the population now has pre-existing immunity due to infection or vaccination, the use of...
4.
Tolksdorf B, Heinze J, Niemeyer D, Rohrs V, Berg J, Drosten C, et al.
Antiviral Res
. 2024 Apr;
226:105879.
PMID: 38599550
Treatment options for COVID-19 remain limited. Here, we report the optimization of an siRNA targeting the highly conserved leader region of SARS-CoV-2. The siRNA was rendered nuclease resistant by the...
5.
Mhlekude B, Postmus D, Stenzel S, Weiner 3rd J, Jansen J, Zapatero-Belinchon F, et al.
PLoS Pathog
. 2023 Sep;
19(9):e1011657.
PMID: 37747932
Inhibitors of bromodomain and extra-terminal proteins (iBETs), including JQ-1, have been suggested as potential prophylactics against SARS-CoV-2 infection. However, molecular mechanisms underlying JQ-1-mediated antiviral activity and its susceptibility to viral...
6.
Vierbaum L, Wojtalewicz N, Grunert H, Zimmermann A, Scholz A, Goseberg S, et al.
Sci Rep
. 2023 Aug;
13(1):13206.
PMID: 37580353
The COVID-19 pandemic illustrated the important role of diagnostic tests, including lateral flow tests (LFTs), in identifying patients and their contacts to slow the spread of infections. INSTAND performed external...
7.
Bosquillon de Jarcy L, Akbil B, Mhlekude B, Leyens J, Postmus D, Harnisch G, et al.
Clin Exp Med
. 2023 May;
23(7):3689-3700.
PMID: 37162650
Glycoprotein 90K, encoded by the interferon-stimulated gene LGALS3BP, displays broad antiviral activity. It reduces HIV-1 infectivity by interfering with Env maturation and virion incorporation, and increases survival of Influenza A...
8.
Nouailles G, Adler J, Pennitz P, Peidli S, Teixeira Alves L, Baumgardt M, et al.
Nat Microbiol
. 2023 Apr;
8(5):860-874.
PMID: 37012419
Vaccines play a critical role in combating the COVID-19 pandemic. Future control of the pandemic requires improved vaccines with high efficacy against newly emerging SARS-CoV-2 variants and the ability to...
9.
Xie Q, Prelli Bozzo C, Eiben L, Noettger S, Kmiec D, Nchioua R, et al.
iScience
. 2023 Mar;
26(4):106395.
PMID: 36968088
Opposing effects of interferon-induced transmembrane proteins (IFITMs 1, 2 and 3) on SARS-CoV-2 infection have been reported. The reasons for this are unclear and the role of IFITMs in infection...
10.
Niemeyer D, Stenzel S, Veith T, Schroeder S, Friedmann K, Weege F, et al.
PLoS Biol
. 2022 Nov;
20(11):e3001871.
PMID: 36383605
Epidemiological data demonstrate that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) Alpha and Delta are more transmissible, infectious, and pathogenic than previous variants. Phenotypic properties of...